Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 


Online Report Subscribers, Click Here
Pricing and Ordering Information

European Markets for Cardiovascular Disease Diagnostic Products
Report #A216 - March 2009
496 Pages – 171 Exhibits
19 Company Profiles


In Europe, more than 4.3 million people die every year from cardiovascular diseases/disorders such as stroke and coronary heart disease (which by itself is the most common cause of death in the region). Cardiovascular conditions result in direct and indirect costs that exceed €192 billion annually in the countries that comprise the European Union.

In 2008, nearly 43 million cardiovascular disease-related invasive and noninvasive diagnostic imaging procedures were performed in Europe—which for the purposes of this report consists of the countries of France, Germany, Italy, Spain, and the United Kingdom. These procedures generated approximately $3.0 billion in corresponding diagnostic imaging product revenues, with noninvasive diagnostic imaging systems sales accounting for 49% of the total, imaging contrast agents/radiopharmaceuticals sales for 30%, and transcatheter diagnostic systems sales for 21%.

This dynamic, new report from Medtech Insight includes analyses of products, current and emerging markets, competitors, and opportunities in the field of diagnostic imaging for cardiovascular disease applications.

Covered topics in this report include angiography catheters, guidewires, and other devices; cardiovascular disease/disorder statistics for Europe; computed tomography systems; contrast agents for cardiovascular disease-related diagnostic X-ray-based imaging, computed tomography, and diagnostic ultrasound procedures; conventional and advanced electrophysiology catheters; conventional X-ray-based imaging systems; diagnostic ultrasound systems; a discussion of the healthcare markets of France, Germany, Italy, Spain, and the United Kingdom; intravascular ultrasound catheters; magnetic resonance imaging systems; nuclear medicine imaging systems; physiologic intravascular stenosis assessment guidewires; and radiopharmaceuticals for cardiovascular disease-related gamma camera and positron emission tomography procedures.

Ordering Information

Title

 Report# Publication
Date		 List Price

European Markets for Cardiovascular Disease Diagnostic Products

A216

 March 2009

$4,850
Order Online:
Single User only (Please call for corporate subscription pricing)		 PDF Only

Print versions of Reports are available upon request for an additional fee.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

EXECUTIVE SUMMARY

i.    Noninvasive Diagnostic Imaging Systems Market Segment

a.   Conventional X-Ray Systems

b.   Computed Tomography Systems

c.    Magnetic Resonance Imaging Systems

d.   Nuclear Medicine Imaging Systems

e.   Diagnostic Ultrasound Systems

ii.    Invasive Diagnostic Imaging Products Market Segment

a.   Angiography Devices

b    Diagnostic Electrophysiology Catheters

c.    Physiologic Intravascular Stenosis Assessment Guidewires

d.   Intravascular Ultrasound Catheters

iii    Imaging Contrast Agents and Radiopharmaceuticals Market Segment

a.   Contrast Agents for Cardiovascular Disease-Related Diagnostic X-Ray-Based Imaging and Computed Tomography Procedures

b.   Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging Procedures

c.    Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound Procedures

iv.         Methodology

 

Exhibit ES-1:    Europe, Cardiovascular Disease-Related Diagnostic Imaging, Combined Procedure Volumes Forecast, 2007-2011

Exhibit ES-2:    Europe, Cardiovascular Disease-Related Diagnostic Imaging, Procedure Volumes Forecast, by Country, 2007-2011

Exhibit ES-3:    Europe, Diagnostic Imaging Products for Cardiovascular Disease-Related Applications, Combined Market Forecast, 2007-2011

Exhibit ES-4:    Europe, Diagnostic Imaging Products for Cardiovascular Disease-Related Applications,  Combined Market Forecast, by Country, 2007-2011

Exhibit ES-5:    Europe, Noninvasive Diagnostic Imaging Systems for Cardiovascular Disease-Related Applications, Combined Market Forecast, 2007-2011

Exhibit ES-6:    Europe, Noninvasive Diagnostic Imaging Systems or Cardiovascular Disease-Related Applications, Market Forecast, by Country, 2007-2011

Exhibit ES-7:    Europe, Conventional X-Ray Imaging Systems  for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011

Exhibit ES-8:    Europe, Computed Tomography Systems for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011

Exhibit ES-9:    Europe, Magnetic Resonance Imaging Systems  for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011

Exhibit ES-10:  Europe, Nuclear Medicine Imaging Systems  for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011

Exhibit ES-11:  Europe, Diagnostic Ultrasound Systems for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011

Exhibit ES-12:  Europe, Invasive Diagnostic Imaging Devices for Cardiovascular Disease-Related Applications, Combined Market Forecast, 2007-2011

Exhibit ES-13:  Europe, Invasive Diagnostic Imaging Systems for Cardiovascular Disease-Related Applications, Market Forecast, by Country, 2007-2011

Exhibit ES-14:  Europe, Angiography Devices, Combined Market Forecast, 2007-2011

Exhibit ES-15:  Europe, Diagnostic Electrophysiology Catheters, Combined Market Forecast, 2007-2011

Exhibit ES-16:  Europe, Physiologic Intravascular Stenosis Assessment Guidewires, Combined Market Forecast, 2007-2011

Exhibit ES-17:  Europe, Intravascular Ultrasound Catheters, Combined Market Forecast, 2007-2011

Exhibit ES-18:  Europe, Contrast Agents and Radiopharmaceuticals for Cardiovascular Disease-Related Diagnostic Imaging Applications, Combined Market Forecast, 2007-2011

Exhibit ES-19:  Europe, Contrast Agents and Radiopharmaceuticals for Cardiovascular Disease-Related Diagnostic Imaging Applications, Market Forecast, by Country, 2007-2011

Exhibit ES-20:  Europe, Contrast Agents for Cardiovascular Disease-Related X-Ray-Based Imaging and Computed Tomography, Combined Market Forecast, 2007-2011

Exhibit ES-21:  Europe, Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging, Combined Market Forecast, 2007-2011

Exhibit ES-22:  Europe, Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound, Combined Market Forecast, 2007-2011

 

1. EUROPEAN HEALTHCARE MARKETS

1.1 The European Union

1.1.1 A Common Currency

1.1.2 Regulatory Policies

1.1.3 Reimbursement

1.1.4 Healthcare Spending

1.2 Selected European National Healthcare Profiles

1.2.1 France

1.2.1.1 Healthcare Organization and Reform

1.2.1.2 Hospital Services

1.2.1.3 Medical Device Reimbursement

1.2.2 Germany 

1.2.2.1 Healthcare Organization and Reform

1.2.2.2 Hospital Services

1.2.2.3 Medical Device Reimbursement

1.2.3 Italy

1.2.3.1 Healthcare Organization and Reform

1.2.3.2 Hospital Services

1.2.3.3 Medical Device Reimbursement

1.2.4 Spain

1.2.4.1 Healthcare Organization and Reform

1.2.4.2 Hospital Services

1.2.4.3 Medical Device Reimbursement

1.2.5 United Kingdom

1.2.5.1 Healthcare Organization and Reform

1.2.5.2 Hospital Services

1.2.5.3 Medical Device Reimbursement

 

Exhibit 1-1:      European Union, Medical Devices Risk Classification System

Exhibit 1-2:      European Union Population Statistics Comparison for the Years 1997, 2007, and 2017

Exhibit 1-3:      France, Selected National Healthcare Statistics

Exhibit 1-4:      Germany, Selected National Healthcare Statistics

Exhibit 1-5:      Italy, Selected National Healthcare Statistics

Exhibit 1-6:      Spain, Selected National Healthcare Statistics

Exhibit 1-7:      United Kingdom, Selected National Healthcare Statistics

 

2. OVERVIEW OF SELECTED CARDIOVASCULAR DISEASES/DISORDERS

2.1 The Heart and Circulatory System

2.1.1 The Cardiac Conduction System

2.1.2 The Heart Valves

2.2 Diseases/Disorders Involving the Vasculature

2.2.1 Coronary Heart Disease

2.2.1.1 Atherosclerosis

2.2.1.1.1 Description

2.2.1.1.2 Statistics

2.2.1.2 Angina Pectoris

2.2.1.2.1 Description

2.2.1.2.2 Statistics

2.2.1.3 Myocardial Infarction

2.2.1.3.1 Description

2.2.1.3.2 Statistics

2.2.2 Hypertension

2.2.2.1 Description

2.2.2.1.1 Systolic and Diastolic Pressures

2.2.2.1.2 Prehypertension

2.2.2.2 Statistics

2.2.3 Aneurysm

2.2.3.1 Description

2.2.3.2 Statistics

2.2.4 Stroke

2.2.4.1 Description

2.2.4.2 Statistics

2.3 Diseases/Disorders Involving The Cardiac Conduction System

2.3.1 Types

2.3.1.1 Bradycardia

2.3.1.1.1 Description

2.3.1.2 Sick Sinus Syndrome

2.3.1.2.1 Description

2.3.1.3 Heart Block

2.3.1.3.1 Description

2.3.1.4 Atrial Fibrillation

2.3.1.4.1 Description

2.3.1.5 Tachycardia

2.3.1.5.1 Description

2.3.1.6 Ventricular Fibrillation

2.3.1.6.1 Description

2.3.2 Statistics

2.4 Diseases/Disorders Involving the Myocardium

2.4.1 Heart Defects

2.4.1.1 Description

2.4.1.2 Statistics

2.4.2 Heart Failure

2.4.2.1 Description

2.2.4.2 Statistics

2.4.3 Rheumatic Fever/Rheumatic Heart Disease

2.4.3.1 Description

2.4.3.2 Statistics

2.4.4 Heart Valve Disorders

2.4.4.1 Types

2.4.4.1.1 Valvular Stenosis

2.4.4.1.1.1 Description

2.4.4.1.2 Valvular Regurgitation

2.4.4.1.2.1 Description

2.4.4.1.3 Valve Prolapse

2.4.4.1.3.1 Description

2.4.4.2 Statistics

 

Exhibit 2-1:      Cross-Section Diagram of the Heart

Exhibit 2-2:      Cross-Section Diagram of the Heart Valves

Exhibit 2-3:      Men, Number of Deaths due to Cardiovascular Disease, Selected European Countries

Exhibit 2-4:      Women, Number of Deaths due to Cardiovascular Disease, Selected European Countries

Exhibit 2-5:      Total Cholesterol Levels in Men, Selected European Countries, 2005 and 2010

Exhibit 2-6:      Total Cholesterol Levels in Women, Selected European Countries, 2005 and 2010

Exhibit 2-7:      Europe, Atherosclerosis Prevalence, by Country

Exhibit 2-8:      Standard Angina Pectoris Classification

Exhibit 2-9:      Europe, Coronary Events Incidence Rates, Selected MONICA Project Populations, by Gender Group

Exhibit 2-10:    Europe, Myocardial Infarction Prevalence, by Country

Exhibit 2-11:    Europe, Systolic Blood Pressure Levels, Selected MONICA Project Populations, by Gender Group

Exhibit 2-12:    Mean Systolic Blood Pressure Levels in Men, Selected European Countries, 2005 and 2010

Exhibit 2-13:    Mean Systolic Blood Pressure Levels in Women, Selected European Countries 2005 and 2010

Exhibit 2-14:    Europe, Hypertension Prevalence, by Country

Exhibit 2-15:    Europe, Aneurysm Prevalence, by Country

Exhibit 2-16:    Europe, Stroke Disability and Mortality, By Selected Country

Exhibit 2-17:    Europe, Stroke Prevalence, by Country

Exhibit 2-18:    Europe, Cardiac Dysrhythmia Prevalence, by Country

Exhibit 2-19:    Congenital Heart Defects, Estimated Number of Simple and Complex Cases in the United Kingdom, 2000 and 2010

Exhibit 2-20:    United Kingdom, Heart Failure Prevalence, Selected Study Data

Exhibit 2-21:    Europe, Heart Failure Prevalence, by Country

Exhibit 2-22:    Rheumatic Heart Disease, Estimated Number of Reported Cases, Selected Countries/Regions

Exhibit 2-23:    Rheumatic Heart Disease Mortality, Selected European Countries

Exhibit 2-24:    Euro Heart Survey on Valvular Heart Disease Patient Population, Native Heart Valve Disorders, by Type

Exhibit 2-25:    Europe, Heart Valve Disorder Prevalence, by Country

 

3. NONINVASIVE DIAGNOSTIC IMAGING PROCEDURES AND PRODUCTS

3.1 Conventional X-Ray Imaging

3.1.1 Procedure Volumes

3.1.2 Products

3.1.3 Market Forecast

3.1.4 Competitors

3.2 Computed Tomography

3.2.1 Procedure Volumes

3.2.2 Products

3.2.3 Market Forecast

3.2.4 Competitors

3.3 Magnetic Resonance Imaging

3.3.1 Procedure Volumes

3.3.2 Products

3.3.3 Market Forecast

3.3.4 Competitors

3.4 Nuclear Medicine Imaging

3.4.1 Procedure Volumes

3.4.2 Products

3.4.3 Market Forecast

3.4.4 Competitors

3.5 Ultrasound Imaging

3.5.1 Procedure Volumes

3.5.2 Products

3.5.3 Market Forecast

3.5.4 Competitors

 

Exhibit 3-1:      Noninvasive Diagnostic Imaging, Selected Applications

Exhibit 3-2:      Europe, Cardiovascular Disease-Related Noninvasive Diagnostic Imaging, Procedure Volumes Forecast, by Country, 2007-2011

Exhibit 3-3:      Europe, Noninvasive Diagnostic Imaging Systems for Cardiovascular Disease-Related Applications, Combined Market Forecast, 2007-2011

Exhibit 3-4:      Europe, Noninvasive Diagnostic Imaging Systems for Cardiovascular Disease-Related Applications, Market Forecast, by Country, 2007-2011

Exhibit 3-5:      Europe, Cardiovascular Disease-Related Conventional X-Ray Imaging, Procedure Volumes Forecast, by Country, 2007-2011

Exhibit 3-6:      2009, Selected Conventional X-Ray-Based Imaging Systems

Exhibit 3-7:      Europe, Conventional X-Ray Imaging Systems for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011

Exhibit 3-8:      France, Conventional X-Ray Imaging Systems or Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-9:      Germany, Conventional X-Ray Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-10:    Italy, Conventional X-Ray Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-11:    Spain, Conventional X-Ray Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-12:    United Kingdom, Conventional X-Ray Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-13:    2008, Europe, Conventional X-Ray Imaging Systems Market, Share by Supplier

Exhibit 3-14:    Europe, Cardiovascular Disease-Related Computed Tomography, Procedure Volumes Forecast, by Country, 2007-2011

Exhibit 3-15:    2009, Selected Computed Tomography Systems

Exhibit 3-16:    Europe, Computed Tomography Systems for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011

Exhibit 3-17:    France, Computed Tomography Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-18:    Germany, Computed Tomography Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-19:    Italy, Computed Tomography Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-20:    Spain, Computed Tomography Systems for Cardiovascular Disease Applications,
Market Forecast, 2007-2011

Exhibit 3-21:    United Kingdom, Computed Tomography Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-22:    2008, Europe, Computed Tomography Systems Market, Share by Supplier

Exhibit 3-23:    Europe, Cardiovascular Disease-Related Magnetic Resonance Imaging, Procedure Volumes Forecast, by Country, 2007-2011

Exhibit 3-24:    2009, Selected Magnetic Resonance Imaging Systems

Exhibit 3-25:    Europe, Magnetic Resonance Imaging Systems for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011

Exhibit 3-26:    France, Magnetic Resonance Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-27:    Germany, Magnetic Resonance Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-28:    Italy, Magnetic Resonance Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-29:    Spain, Magnetic Resonance Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-30:    United Kingdom, Magnetic Resonance Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-31:    2008, Europe, Magnetic Resonance Imaging Systems Market, Share by Supplier

Exhibit 3-32:    Europe, Cardiovascular Disease-Related Nuclear Medicine Imaging, Procedure Volumes Forecast, by Country, 2007-2011

Exhibit 3-33:    2009, Selected Nuclear Medicine Imaging Systems

Exhibit 3-34:    Europe, Nuclear Medicine Imaging Systems for Cardiovascular Disease Applications, Combined Market Forecast, 2007-2011

Exhibit 3-35:    France, Nuclear Medicine Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-36:    Germany, Nuclear Medicine Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-37:    Italy, Nuclear Medicine Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-38:    Spain, Nuclear Medicine Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-39:    United Kingdom, Nuclear Medicine Imaging Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-40:    2008, Europe, Nuclear Medicine Imaging Systems Market, Share by Supplier

Exhibit 3-41:    Europe, Cardiovascular Disease-Related Diagnostic Ultrasound, Procedure Volumes Forecast, by Country, 2007-2011

Exhibit 3-42:    2009, Selected Diagnostic Ultrasound Systems

Exhibit 3-43:    Europe, Diagnostic Ultrasound Systems for Cardiovascular Disease Applications, Combined Market Forecast,  2007-2011

Exhibit 3-44:    France, Diagnostic Ultrasound Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-45:    Germany, Diagnostic Ultrasound Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-46:    Italy, Diagnostic Ultrasound Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-47:    Spain, Diagnostic Ultrasound Systems for Cardiovascular Disease Applications,
Market Forecast, 2007-2011

Exhibit 3-48:    United Kingdom, Diagnostic Ultrasound Systems for Cardiovascular Disease Applications, Market Forecast, 2007-2011

Exhibit 3-49:    2008, Europe, Diagnostic Ultrasound Imaging Systems Market, Share by Supplier

 

4. INVASIVE DIAGNOSTIC IMAGING PROCEDURES AND PRODUCTS

4.1 Angiography

4.1.1 Procedures

4.1.2 Products

4.1.3 Market Forecast

4.1.4 Competitors

4.2 Electrophysiology Studies

4.2.1 Procedures

4.2.2 Products

4.2.3 Market Forecast

4.2.4 Competitors

4.3 Guidewire-Based Physiologic Intravascular Stenosis Assessment

4.3.1 Procedures

4.3.2 Products

4.3.3 Market Forecast

4.3.4 Competitors

4.4 Intravascular Ultrasound

4.4.1 Procedures

4.4.2 Products

4.4.3 Market Forecast

4.4.4 Competitors

 

Exhibit 4-1:      Europe, Cardiovascular Disease-Related Invasive Diagnostic Imaging, Procedure Volumes Forecast, by Country, 2007-2011

Exhibit 4-2:      Europe, Invasive Diagnostic Imaging Devices for Cardiovascular Disease-Related Applications, Combined Market Forecast, 2007-2011

Exhibit 4-3:      Europe, Invasive Diagnostic Imaging Systems for Cardiovascular Disease-Related Applications, Market Forecast, by Country, 2007-2011

Exhibit 4-4:      Europe, Angiography, Procedure Volumes Forecast, by Country, 2007-2011

Exhibit 4-5:      2009, Selected Angiography Catheters

Exhibit 4-6:      2009, Selected Diagnostic Guidewires

Exhibit 4-7:      2009, Selected Introducers/Sheaths

Exhibit 4-8:      Europe, Angiography Devices, Combined Market Forecast, 2007-2011

Exhibit 4-9:      France, Angiography Devices, Market Forecast, 2007-2011

Exhibit 4-10:    Germany, Angiography Devices, Market Forecast, 2007-2011

Exhibit 4-11:    Italy, Angiography Devices, Market Forecast, 2007-2011

Exhibit 4-12:    Spain, Angiography Devices, Market Forecast, 2007-2011

Exhibit 4-13:    United Kingdom, Angiography Devices, Market Forecast, 2007-2011

Exhibit 4-14:    2008, Europe, Angiography Devices Market, Share by Supplier

Exhibit 4-15:    Europe, Electrophysiology Studies, Procedure Volumes Forecast, by Country, 2007-2011

Exhibit 4-16:    2009, Selected Diagnostic Electrophysiology Catheters

Exhibit 4-17:    Europe, Diagnostic Electrophysiology Catheters, Combined Market Forecast, 2007-2011

Exhibit 4-18:    France, Diagnostic Electrophysiology Catheters, Market Forecast, 2007-2011

Exhibit 4-19:    Germany, Diagnostic Electrophysiology Catheters, Market Forecast, 2007-2011

Exhibit 4-20:    Italy, Diagnostic Electrophysiology Catheters, Market Forecast, 2007-2011

Exhibit 4-21:    Spain, Diagnostic Electrophysiology Catheters, Market Forecast, 2007-2011

Exhibit 4-22:    United Kingdom, Diagnostic Electrophysiology Catheters, Market Forecast, 2007-2011

Exhibit 4-23:    2008, Europe, Diagnostic Electrophysiology Catheters Market, Share by Supplier

Exhibit 4-24:    Europe, Guidewire-Based Physiologic Intravascular Stenosis Assessment, Procedure Volumes Forecast, by Country, 2007-2011

Exhibit 4-25:    2009, Selected Guidewires for Physiologic Intravascular Stenosis Assessment

Exhibit 4-26:    Europe, Physiologic Intravascular Stenosis Assessment Guidewires, Combined Market Forecast, 2007-2011

Exhibit 4-27:    France, Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2007-2011

Exhibit 4-28:    Germany, Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2007-2011

Exhibit 4-29:    Italy, Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2007-2011

Exhibit 4-30:    Spain, Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2007-2011

Exhibit 4-31:    United Kingdom, Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2007-2011

Exhibit 4-32:    2008, Europe, Physiologic Intravascular Stenosis Assessment Guidewires Market, Share by Supplier

Exhibit 4-33:    Europe, Intravascular Ultrasound, Procedure Volumes Forecast, by Country, 2007-2011

Exhibit 4-34:    2009, Selected Intravascular Ultrasound Catheters

Exhibit 4-35:    Europe, Intravascular Ultrasound Catheters, Combined Market Forecast, 2007-2011

Exhibit 4-36:    France, Intravascular Ultrasound Catheters, Market Forecast, 2007-2011

Exhibit 4-37:    Germany, Intravascular Ultrasound Catheters, Market Forecast, 2007-2011

Exhibit 4-38:    Italy, Intravascular Ultrasound Catheters, Market Forecast, 2007-2011

Exhibit 4-39:    Spain, Intravascular Ultrasound Catheters, Market Forecast, 2007-2011

Exhibit 4-40:    United Kingdom, Intravascular Ultrasound Catheters, Market Forecast, 2007-2011

Exhibit 4-41:    2008, Europe, Intravascular Ultrasound Catheters Market, Share by Supplier

 

5. IMAGING CONTRAST AGENTS AND RADIOPHARMACEUTICALS

5.1 Contrast Agents for Cardiovascular Disease-Related Diagnostic X-Ray-Based Imaging and Computed Tomography Procedures

5.1.1 Procedures

5.1.2 Products

5.1.3 Market Forecast

5.1.4 Competitors

5.2 Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging Procedures

5.2.1 Procedures

5.2.2 Products

5.2.3 Market Forecast

5.2.4 Competitors

5.3 Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound Procedures

5.3.1 Procedures

5.3.2 Products

5.3.3 Market Forecast

5.3.4 Competitors

 

Exhibit 5-1:      Europe, Cardiovascular Disease-Related Diagnostic Imaging Performed with Contrast Agents/Radiopharmaceuticals, Procedure Volumes Forecast, by Country, 2007-2011

Exhibit 5-2:      Europe, Contrast Agents and Radiopharmaceuticals for Cardiovascular Disease-Related Diagnostic Imaging Applications, Combined Market Forecast, 2007-2011

Exhibit 5-3:      Europe, Contrast Agents and Radiopharmaceuticals for Cardiovascular Disease-Related Diagnostic Imaging Applications, Market Forecast, by Country, 2007-2011

Exhibit 5-4:      Europe, Cardiovascular Disease-Related Contrast-Enhanced X-Ray-Based Imaging and Computed Tomography, Procedure Volumes Forecast, by Country, 2007-2011

Exhibit 5-5:      Europe, Contrast Agents for Cardiovascular Disease-Related X-Ray-Based Imaging and Computed Tomography, Combined Market Forecast, 2007-2011

Exhibit 5-6:      France, Contrast Agents for Cardiovascular Disease-Related X-Ray-Based Imaging and Computed Tomography, Market Forecast, 2007-2011

Exhibit 5-7:      Germany, Contrast Agents for Cardiovascular Disease-Related X-Ray-Based Imaging and Computed Tomography, Market Forecast, 2007-2011

Exhibit 5-8:      Italy, Contrast Agents for Cardiovascular Disease-Related X-Ray-Based Imaging and Computed Tomography, Market Forecast, 2007-2011

Exhibit 5-9:      Spain, Contrast Agents for Cardiovascular Disease-Related X-Ray-Based Imaging and Computed Tomography, Market Forecast, 2007-2011

Exhibit 5-10:    United Kingdom, Contrast Agents for Cardiovascular Disease-Related X-Ray-Based Imaging and Computed Tomography, Market Forecast, 2007-2011

Exhibit 5-11:    2008, Europe, Market for Contrast Agents for Cardiovascular Disease-Related X-Ray-Based Imaging and Computed Tomography, Share by Supplier

Exhibit 5-12:    Europe, Cardiovascular Disease-Related Gamma Camera Imaging and Positron Emission Tomography Scanning, Procedure Volumes Forecast, by Country, 2007-2011

Exhibit 5-13:    Europe, Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging, Combined Market Forecast, 2007-2011

Exhibit 5-14:    France, Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging, Market Forecast, 2007-2011

Exhibit 5-15:    Germany, Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging, Market Forecast, 2007-2011

Exhibit5-16:     Italy, Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging, Market Forecast, 2007-2011

Exhibit 5-17:    Spain, Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging, Market Forecast, 2007-2011

Exhibit 5-18:    United Kingdom, Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging, Market Forecast, 2007-2011

Exhibit 5-19:    2008, Europe, Market for Radiopharmaceuticals for Cardiovascular Disease-Related Nuclear Medicine Imaging, Share by Supplier

Exhibit 5-20:    Europe, Cardiovascular Disease-Related Contrast-Enhanced Diagnostic Ultrasound, Procedure Volumes Forecast, by Country, 2007-2011

Exhibit 5-21:    Europe, Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound, Combined Market Forecast, 2007-2011

 

Exhibit 5-22:    France, Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound, Market Forecast, 2007-2011

Exhibit 5-23:    Germany, Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound, Market Forecast, 2007-2011

Exhibit5-24:     Italy, Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound, Market Forecast, 2007-2011

Exhibit 5-25:    Spain, Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound, Market Forecast, 2007-2011

Exhibit 5-26:    United Kingdom, Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound, Market Forecast, 2007-2011

Exhibit 5-27:    2008, Europe, Market for Contrast Agents for Cardiovascular Disease-Related Diagnostic Ultrasound, Share by Supplier

 

6. COMPANY PROFILES

6.1    AngioDynamics, Inc.

6.2    C.R. Bard, Inc.

6.3    Bayer Schering Pharma/Bayer HealthCare/Bayer Group

6.4    Boston Scientific Corporation

6.5    Bracco Imaging/Bracco Group

6.6    Cook Group, Inc.

6.7    GE Healthcare, Inc./General Electric Company

6.8    Guerbet Group

6.9    Hitachi Medical Systems Europe/Hitachi

6.10  Johnson & Johnson

6.11  Lantheus Medical Imaging, Inc./Avista Capital Partners

6.12  Mallinckrodt Pharmaceuticals/Covidien LTD

6.13  Medtronic, Inc.

6.14  Philips Healthcare/Royal Philips Electronics NV

6.15  Siemens Healthcare/Siemens AG

6.16  St. Jude Medical, Inc.

6.17  Terumo Interventional Systems/Terumo Corporation

6.18  Toshiba Medical Systems Europe/Toshiba

6.19  Volcano Corporation

 

APPENDIX: COMPANY LISTING

 

 

To order reports or obtain information about special pre-publication offers from within the U.S., contact sales@medtechinsight.com. From outside the U.S., contact internationalsales@medtechinsight.com. You can also call 1.949.453.0071 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.453.0072.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home